Dr Guliz Ozcan at University College London will look to better understand how small amyloid proteins cause insomnia in people with Alzheimer’s disease.
Researchers at University College of London are using brain tissue samples to understand the role calcium deposits in brain cells have with the development of Alzheimer’s disease.
The US Food and Drug Administration (FDA) has granted full approval to the drug lecanemab (known commercially as Leqembi) for people in the US with confirmed amyloid positivity and a diagnosis of mild cognitive impairment (MCI) or early-stage Alzheimer’s disease.
TV presenter and Alzheimer’s Research UK supporter Fiona Phillips has been diagnosed with young onset Alzheimer’s disease.
A large, observational Danish study has reported that menopausal women who use hormone replacement therapy (HRT) have an increased the risk of developing dementia in later life.
Lots of factors affect a person’s risk of getting Alzheimer’s disease, the number one cause of dementia. It’s a complex mix of lifestyle, health and age, but our genetic makeup plays a particularly important role in determining whether we will get Alzheimer’s.
Researchers in Newcastle are developing a new technique to screen for new drug targets to treat Alzheimer’s disease
Researchers from the University of Oxford will investigate how and why some people are ‘resilient’ to developing dementia to find new treatment targets.
Researchers are unpicking the links between obesity in parents and the effect to their children’s risk of developing Alzheimer’s later in life
Researchers at King’s College London are unpicking how mutations in specific proteins affect brain inflammation in frontotemporal dementia.